CIAM
PLRX icon

Caitong International Asset Management’s Pliant Therapeutics PLRX Stock Holding History

Caitong International Asset Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9 Buy
8
+4
+100% +$5 ﹤0.01% 2657
2026
Q1 		$5 Buy
4
+3
+300% +$4 ﹤0.01% 2289
2025
Q4 		$1 Sell
1
-2,046
-100% -$3.07K ﹤0.01% 1831
2025
Q3 		$3.03K Sell
2,047
-3,501
-63% -$5.34K ﹤0.01% 1327
2025
Q2 		$6.44K Buy
+5,548
New +$7.84K ﹤0.01% 908

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Caitong International Asset Management's PLRX Position: Q2 2026 in Review

Caitong International Asset Management increased its Pliant Therapeutics (PLRX) stake by 100% in Q2 2026, buying an estimated $5 and bringing the position to 8 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #2657.

Caitong International Asset Management first reported a position in PLRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.44K in Q2 2025. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Caitong International Asset Management held 8 shares of Pliant Therapeutics worth $9 as of Q2 2026.
  • Caitong International Asset Management bought 4 Pliant Therapeutics shares in Q2 2026, an estimated $5.
  • Pliant Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2657 holding.
  • Caitong International Asset Management first reported a position in Pliant Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Pliant Therapeutics position peaked at $6.44K in Q2 2025.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.